The metabolic rate during the time course of salicylate antipyresis in the rabbit
The processes concerned with the production and loss of body heat in sodium salicylate or acetylsalicylic acid antipyresis were investigated in adult rabbits at an ambient temperature of 21.5 ± 0.5°C. The experimental fever elicited by i.v. injection of lipopolysaccharide Escherichia coli (1 μg/kg)...
Gespeichert in:
Veröffentlicht in: | European journal of pharmacology 1983-12, Vol.96 (3), p.193-200 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 200 |
---|---|
container_issue | 3 |
container_start_page | 193 |
container_title | European journal of pharmacology |
container_volume | 96 |
creator | Gagało, Iwona T. Hać, Ewa E. Korolkiewicz, Konstanty Z. |
description | The processes concerned with the production and loss of body heat in sodium salicylate or acetylsalicylic acid antipyresis were investigated in adult rabbits at an ambient temperature of 21.5 ± 0.5°C. The experimental fever elicited by i.v. injection of lipopolysaccharide Escherichia coli (1 μg/kg) was accompanied by increases in O
2 consumption and CO
2 production as well as decreases in convective heat loss. Pretreatment with 200 mg/kg of sodium salicylate (an hour's i.v. infusion) or with the same dose of acetylsalicylic acid (per os) significantly reduced pyrogen fever but the magnitude of O
2 consumption and CO
2 production remained at least at the febrile level. In the case of sodium salicylate, the level was even exceeded. At the same time both salicylates activated heat dissipation as manifested by decreases in vasomotor tone and tachypnea. Thus, it is apparent that the antipyretic effect of salicylates may develop without the inhibition of heat production. Heat loss processes initiated by these drugs are responsible for the antipyresis. |
doi_str_mv | 10.1016/0014-2999(83)90308-4 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80907730</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0014299983903084</els_id><sourcerecordid>80907730</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-b12b12a862e90be9a1f4c1c6bf54064dd30f197395ffcb47510d8ca370e6c15c3</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotVb_gcKeRA-rk012s7kIUvyCggj1HLLZiUb2oyZZof_erS09CgNzeJ-ZYR5CzincUKDFLQDlaSalvCrZtQQGZcoPyJSWQqYgaHZIpnvkmJyE8AUAuczyCZkUPCukyKfkbfmJSYtRV33jTOJ1xKQevOs-kjgm0bWYmH7wAZPeJkGP0LrZQLqLbrX2GFxIXPcHe11VLp6SI6ubgGe7PiPvjw_L-XO6eH16md8vUsNyEdOKZmPpsshQQoVSU8sNNUVlcw4Fr2sGlkrBZG6tqbjIKdSl0UwAFobmhs3I5XbvyvffA4aoWhcMNo3usB-CKkGCEAxGkG9B4_sQPFq18q7Vfq0oqI1JtdGkNppUydSfScXHsYvd_qFqsd4P7dSN-d02x_HJH4deBeOwM1g7jyaqunf_H_gF7YKCqw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80907730</pqid></control><display><type>article</type><title>The metabolic rate during the time course of salicylate antipyresis in the rabbit</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Gagało, Iwona T. ; Hać, Ewa E. ; Korolkiewicz, Konstanty Z.</creator><creatorcontrib>Gagało, Iwona T. ; Hać, Ewa E. ; Korolkiewicz, Konstanty Z.</creatorcontrib><description>The processes concerned with the production and loss of body heat in sodium salicylate or acetylsalicylic acid antipyresis were investigated in adult rabbits at an ambient temperature of 21.5 ± 0.5°C. The experimental fever elicited by i.v. injection of lipopolysaccharide Escherichia coli (1 μg/kg) was accompanied by increases in O
2 consumption and CO
2 production as well as decreases in convective heat loss. Pretreatment with 200 mg/kg of sodium salicylate (an hour's i.v. infusion) or with the same dose of acetylsalicylic acid (per os) significantly reduced pyrogen fever but the magnitude of O
2 consumption and CO
2 production remained at least at the febrile level. In the case of sodium salicylate, the level was even exceeded. At the same time both salicylates activated heat dissipation as manifested by decreases in vasomotor tone and tachypnea. Thus, it is apparent that the antipyretic effect of salicylates may develop without the inhibition of heat production. Heat loss processes initiated by these drugs are responsible for the antipyresis.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/0014-2999(83)90308-4</identifier><identifier>PMID: 6426975</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Body Temperature - drug effects ; Body Temperature Regulation - drug effects ; Carbon Dioxide - biosynthesis ; CO 2 production ; Escherichia coli Infections ; Lipopolysaccharides - administration & dosage ; Male ; O 2 consumption ; Oxygen Consumption - drug effects ; Rabbits ; Respiration - drug effects ; Respiratory frequency ; Salicylate antipyresis ; Salicylates - blood ; Salicylates - pharmacology ; Skin temperature ; Skin Temperature - drug effects ; Time Factors</subject><ispartof>European journal of pharmacology, 1983-12, Vol.96 (3), p.193-200</ispartof><rights>1983</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-b12b12a862e90be9a1f4c1c6bf54064dd30f197395ffcb47510d8ca370e6c15c3</citedby><cites>FETCH-LOGICAL-c357t-b12b12a862e90be9a1f4c1c6bf54064dd30f197395ffcb47510d8ca370e6c15c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0014-2999(83)90308-4$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27911,27912,45982</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6426975$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gagało, Iwona T.</creatorcontrib><creatorcontrib>Hać, Ewa E.</creatorcontrib><creatorcontrib>Korolkiewicz, Konstanty Z.</creatorcontrib><title>The metabolic rate during the time course of salicylate antipyresis in the rabbit</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>The processes concerned with the production and loss of body heat in sodium salicylate or acetylsalicylic acid antipyresis were investigated in adult rabbits at an ambient temperature of 21.5 ± 0.5°C. The experimental fever elicited by i.v. injection of lipopolysaccharide Escherichia coli (1 μg/kg) was accompanied by increases in O
2 consumption and CO
2 production as well as decreases in convective heat loss. Pretreatment with 200 mg/kg of sodium salicylate (an hour's i.v. infusion) or with the same dose of acetylsalicylic acid (per os) significantly reduced pyrogen fever but the magnitude of O
2 consumption and CO
2 production remained at least at the febrile level. In the case of sodium salicylate, the level was even exceeded. At the same time both salicylates activated heat dissipation as manifested by decreases in vasomotor tone and tachypnea. Thus, it is apparent that the antipyretic effect of salicylates may develop without the inhibition of heat production. Heat loss processes initiated by these drugs are responsible for the antipyresis.</description><subject>Animals</subject><subject>Body Temperature - drug effects</subject><subject>Body Temperature Regulation - drug effects</subject><subject>Carbon Dioxide - biosynthesis</subject><subject>CO 2 production</subject><subject>Escherichia coli Infections</subject><subject>Lipopolysaccharides - administration & dosage</subject><subject>Male</subject><subject>O 2 consumption</subject><subject>Oxygen Consumption - drug effects</subject><subject>Rabbits</subject><subject>Respiration - drug effects</subject><subject>Respiratory frequency</subject><subject>Salicylate antipyresis</subject><subject>Salicylates - blood</subject><subject>Salicylates - pharmacology</subject><subject>Skin temperature</subject><subject>Skin Temperature - drug effects</subject><subject>Time Factors</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMotVb_gcKeRA-rk012s7kIUvyCggj1HLLZiUb2oyZZof_erS09CgNzeJ-ZYR5CzincUKDFLQDlaSalvCrZtQQGZcoPyJSWQqYgaHZIpnvkmJyE8AUAuczyCZkUPCukyKfkbfmJSYtRV33jTOJ1xKQevOs-kjgm0bWYmH7wAZPeJkGP0LrZQLqLbrX2GFxIXPcHe11VLp6SI6ubgGe7PiPvjw_L-XO6eH16md8vUsNyEdOKZmPpsshQQoVSU8sNNUVlcw4Fr2sGlkrBZG6tqbjIKdSl0UwAFobmhs3I5XbvyvffA4aoWhcMNo3usB-CKkGCEAxGkG9B4_sQPFq18q7Vfq0oqI1JtdGkNppUydSfScXHsYvd_qFqsd4P7dSN-d02x_HJH4deBeOwM1g7jyaqunf_H_gF7YKCqw</recordid><startdate>19831223</startdate><enddate>19831223</enddate><creator>Gagało, Iwona T.</creator><creator>Hać, Ewa E.</creator><creator>Korolkiewicz, Konstanty Z.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19831223</creationdate><title>The metabolic rate during the time course of salicylate antipyresis in the rabbit</title><author>Gagało, Iwona T. ; Hać, Ewa E. ; Korolkiewicz, Konstanty Z.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-b12b12a862e90be9a1f4c1c6bf54064dd30f197395ffcb47510d8ca370e6c15c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Animals</topic><topic>Body Temperature - drug effects</topic><topic>Body Temperature Regulation - drug effects</topic><topic>Carbon Dioxide - biosynthesis</topic><topic>CO 2 production</topic><topic>Escherichia coli Infections</topic><topic>Lipopolysaccharides - administration & dosage</topic><topic>Male</topic><topic>O 2 consumption</topic><topic>Oxygen Consumption - drug effects</topic><topic>Rabbits</topic><topic>Respiration - drug effects</topic><topic>Respiratory frequency</topic><topic>Salicylate antipyresis</topic><topic>Salicylates - blood</topic><topic>Salicylates - pharmacology</topic><topic>Skin temperature</topic><topic>Skin Temperature - drug effects</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gagało, Iwona T.</creatorcontrib><creatorcontrib>Hać, Ewa E.</creatorcontrib><creatorcontrib>Korolkiewicz, Konstanty Z.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gagało, Iwona T.</au><au>Hać, Ewa E.</au><au>Korolkiewicz, Konstanty Z.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The metabolic rate during the time course of salicylate antipyresis in the rabbit</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>1983-12-23</date><risdate>1983</risdate><volume>96</volume><issue>3</issue><spage>193</spage><epage>200</epage><pages>193-200</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><abstract>The processes concerned with the production and loss of body heat in sodium salicylate or acetylsalicylic acid antipyresis were investigated in adult rabbits at an ambient temperature of 21.5 ± 0.5°C. The experimental fever elicited by i.v. injection of lipopolysaccharide Escherichia coli (1 μg/kg) was accompanied by increases in O
2 consumption and CO
2 production as well as decreases in convective heat loss. Pretreatment with 200 mg/kg of sodium salicylate (an hour's i.v. infusion) or with the same dose of acetylsalicylic acid (per os) significantly reduced pyrogen fever but the magnitude of O
2 consumption and CO
2 production remained at least at the febrile level. In the case of sodium salicylate, the level was even exceeded. At the same time both salicylates activated heat dissipation as manifested by decreases in vasomotor tone and tachypnea. Thus, it is apparent that the antipyretic effect of salicylates may develop without the inhibition of heat production. Heat loss processes initiated by these drugs are responsible for the antipyresis.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>6426975</pmid><doi>10.1016/0014-2999(83)90308-4</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2999 |
ispartof | European journal of pharmacology, 1983-12, Vol.96 (3), p.193-200 |
issn | 0014-2999 1879-0712 |
language | eng |
recordid | cdi_proquest_miscellaneous_80907730 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Animals Body Temperature - drug effects Body Temperature Regulation - drug effects Carbon Dioxide - biosynthesis CO 2 production Escherichia coli Infections Lipopolysaccharides - administration & dosage Male O 2 consumption Oxygen Consumption - drug effects Rabbits Respiration - drug effects Respiratory frequency Salicylate antipyresis Salicylates - blood Salicylates - pharmacology Skin temperature Skin Temperature - drug effects Time Factors |
title | The metabolic rate during the time course of salicylate antipyresis in the rabbit |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T23%3A53%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20metabolic%20rate%20during%20the%20time%20course%20of%20salicylate%20antipyresis%20in%20the%20rabbit&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Gaga%C5%82o,%20Iwona%20T.&rft.date=1983-12-23&rft.volume=96&rft.issue=3&rft.spage=193&rft.epage=200&rft.pages=193-200&rft.issn=0014-2999&rft.eissn=1879-0712&rft_id=info:doi/10.1016/0014-2999(83)90308-4&rft_dat=%3Cproquest_cross%3E80907730%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80907730&rft_id=info:pmid/6426975&rft_els_id=0014299983903084&rfr_iscdi=true |